April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
April 03, 2026
ADA Member Advantage-endorsed CyraCom joins Propio Language Services
April 03, 2026
AI Shows Dermatologist-Level Accuracy in Melanoma Diagnosis but Needs Validation
Latest Headlines
View More
April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
Open Access Has a Dirty Secret, Surgical Editors Say
2
Postmortem Blood Cultures May Aid Autopsy Analysis
3
Survey: 96% of Optometrists Assess Smoking Status
4
Vitamin D May Aid Hearing Recovery in Pilot Trial
5
Medical Oddities: When Men Face Catcalling
6
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
Conference Coverage
2026 ASCO GI
American College of Cardiology's 75th Annual Scientific Session & Expo
April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
April 01, 2026
Tirzepatide Linked to Lower Cardiorenal Events
Clinical Guidelines
View More
Commentary & Perspectives
View More
April 03, 2026
Was the GLP-1 Problem Always Cost?
April 02, 2026
Genomic Data Tracks Measles Spread
April 02, 2026
Honoring Chromatography Educator Peter W. Carr (1944–2025)
FDA & Government News
View More
April 02, 2026
CDC Lists Dozens of Infectious Disease Tests as Unavailable
April 02, 2026
USDA Alerts on Lead in Walmart Chicken Nuggets
April 02, 2026
Genomic Data Tracks Measles Spread
April 01, 2026
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
Business Management
View More
March 31, 2026
